Corbin E Goerlich1, Bartley Griffith2, Peter Hanna3, Susie N Hong3, David Ayares4, Avneesh K Singh2, Muhammad M Mohiuddin5. 1. Department of Surgery, The University of Maryland School of Medicine, Baltimore, Md; Department of Surgery, The Johns Hopkins School of Medicine, Baltimore, Md. 2. Department of Surgery, The University of Maryland School of Medicine, Baltimore, Md. 3. Department of Cardiology, The University of Maryland School of Medicine, Baltimore, Md. 4. Revivicor, Blacksburg, Va. 5. Department of Surgery, The University of Maryland School of Medicine, Baltimore, Md. Electronic address: MMohiuddin@som.umaryland.edu.
Abstract
OBJECTIVE: Genetically engineered pigs are thought to be an alternative organ source for patients in end-stage heart failure unable to receive a timely allograft. However, cardiac xenografts exhibit growth and diastolic heart failure within 1 month after transplantation. Grafts function for up to 6 months, but only after administration of temsirolimus and afterload-reducing agents to reduce this growth. In this study we investigated the growth and hemodynamics of growth hormone receptor (GHR) knockout xenografts, without the use of adjuncts to prevent intrinsic graft growth after transplantation. METHODS: Genetically engineered pig hearts were transplanted orthotopically into weight-matched baboons between 15 and 30 kg, using continuous perfusion preservation before implantation (n = 5). Xenografts included knockout of carbohydrate antigens and knockin of human transgenes for thromboregulation, complement regulation, and inflammation reduction (grafts with intact growth hormone, n = 2). Three grafts contained the additional knockout of GHR (GHR knockout grafts; n = 3). Transthoracic echocardiograms were obtained twice monthly and comprehensively analyzed by a blinded cardiologist. Hemodynamics were measured longitudinally after transplantation. RESULTS: All xenografts demonstrated life-supporting function after transplantation. There was no difference in intrinsic growth, measured using septal and posterior wall thickness and left ventricular mass, on transthoracic echocardiogram out to 1 month in either GHR knockout or GHR intact grafts. However, hypertrophy of the septal and posterior wall was markedly elevated by 2 months post transplantation. There was minimal hypertrophy out to 6 months in GHR knockout grafts. Physiologic mismatch was present in all grafts after transplantation, which is largely independent of growth. CONCLUSIONS: Xenografts with GHR knockout show reduced post-transplantation xenograft growth using echocardiography >6 months after transplantation, without the need for other adjuncts.
OBJECTIVE: Genetically engineered pigs are thought to be an alternative organ source for patients in end-stage heart failure unable to receive a timely allograft. However, cardiac xenografts exhibit growth and diastolic heart failure within 1 month after transplantation. Grafts function for up to 6 months, but only after administration of temsirolimus and afterload-reducing agents to reduce this growth. In this study we investigated the growth and hemodynamics of growth hormone receptor (GHR) knockout xenografts, without the use of adjuncts to prevent intrinsic graft growth after transplantation. METHODS: Genetically engineered pig hearts were transplanted orthotopically into weight-matched baboons between 15 and 30 kg, using continuous perfusion preservation before implantation (n = 5). Xenografts included knockout of carbohydrate antigens and knockin of human transgenes for thromboregulation, complement regulation, and inflammation reduction (grafts with intact growth hormone, n = 2). Three grafts contained the additional knockout of GHR (GHR knockout grafts; n = 3). Transthoracic echocardiograms were obtained twice monthly and comprehensively analyzed by a blinded cardiologist. Hemodynamics were measured longitudinally after transplantation. RESULTS: All xenografts demonstrated life-supporting function after transplantation. There was no difference in intrinsic growth, measured using septal and posterior wall thickness and left ventricular mass, on transthoracic echocardiogram out to 1 month in either GHR knockout or GHR intact grafts. However, hypertrophy of the septal and posterior wall was markedly elevated by 2 months post transplantation. There was minimal hypertrophy out to 6 months in GHR knockout grafts. Physiologic mismatch was present in all grafts after transplantation, which is largely independent of growth. CONCLUSIONS: Xenografts with GHR knockout show reduced post-transplantation xenograft growth using echocardiography >6 months after transplantation, without the need for other adjuncts.
Authors: Matthias Längin; Mark Konrad; Bruno Reichart; Tanja Mayr; Stephanie Vandewiele; Johannes Postrach; Maren Mokelke; Julia Radan; Paolo Brenner; Andreas Bauer; Jan-Michael Abicht Journal: Xenotransplantation Date: 2019-12-19 Impact factor: 3.907
Authors: K A Horvath; P C Corcoran; A K Singh; R F Hoyt; C Carrier; M L Thomas; M M Mohiuddin Journal: Transplant Proc Date: 2010 Jul-Aug Impact factor: 1.066
Authors: Arne Hinrichs; Evamaria O Riedel; Nikolai Klymiuk; Andreas Blutke; Elisabeth Kemter; Matthias Längin; Maik Dahlhoff; Barbara Keßler; Mayuko Kurome; Valeri Zakhartchenko; Eva-Maria Jemiller; David Ayares; Martin Bidlingmaier; Florian Flenkenthaler; Martin Hrabĕ de Angelis; Georg J Arnold; Bruno Reichart; Thomas Fröhlich; Eckhard Wolf Journal: Xenotransplantation Date: 2020-11-25 Impact factor: 3.907
Authors: Richard N Pierson; Jay A Fishman; Gregory D Lewis; David A D'Alessandro; Margaret R Connolly; Lars Burdorf; Joren C Madsen; Agnes M Azimzadeh Journal: Circulation Date: 2020-10-05 Impact factor: 29.690
Authors: Avneesh K Singh; Bartley P Griffith; Corbin E Goerlich; David Ayares; Muhammad M Mohiuddin Journal: Xenotransplantation Date: 2022-09-20 Impact factor: 3.788
Authors: Amber N Carrier; Anjali Verma; Muhammad Mohiuddin; Manuel Pascual; Yannick D Muller; Alban Longchamp; Chandra Bhati; Leo H Buhler; Daniel G Maluf; Raphael P H Meier Journal: Front Immunol Date: 2022-06-09 Impact factor: 8.786
Authors: Silvio H Litovsky; Jeremy B Foote; Abhijit Jagdale; Gregory Walcott; Hayato Iwase; Mohamed H Bikhet; Takayuki Yamamoto; Christophe Hansen-Estruch; Mohamed B Ezzelarab; David Ayares; Waldemar F Carlo; Leslie A Rhodes; Jack H Crawford; Santiago Borasino; Robert J Dabal; Luz A Padilla; Hidetaka Hara; David K C Cooper; David C Cleveland Journal: Ann Transplant Date: 2022-07-05 Impact factor: 1.479
Authors: Avneesh K Singh; Corbin E Goerlich; Aakash M Shah; Tianshu Zhang; Ivan Tatarov; David Ayares; Keith A Horvath; Muhammad M Mohiuddin Journal: Transpl Int Date: 2022-03-23 Impact factor: 3.782
Authors: Aakash Shah; Corbin E Goerlich; Chetan Pasrija; Jeffrey Hirsch; Stacy Fisher; Patrick Odonkor; Erik Strauss; David Ayares; Muhammad M Mohiuddin; Bartley P Griffith Journal: JACC Case Rep Date: 2022-07-07